These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12193557)

  • 1. Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification.
    Cnop M; Hannaert JC; Grupping AY; Pipeleers DG
    Endocrinology; 2002 Sep; 143(9):3449-53. PubMed ID: 12193557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cholesterol feeding on the susceptibility of lipoproteins to oxidative modification.
    Nenseter MS; Gudmundsen O; Malterud KE; Berg T; Drevon CA
    Biochim Biophys Acta; 1994 Jul; 1213(2):207-14. PubMed ID: 8025132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low density lipoprotein binding and uptake by human and rat islet beta cells.
    Grupping AY; Cnop M; Van Schravendijk CF; Hannaert JC; Van Berkel TJ; Pipeleers DG
    Endocrinology; 1997 Oct; 138(10):4064-8. PubMed ID: 9322913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very low density and low density lipoproteins induce nitric oxide synthesis in macrophages.
    Mohan PF; Desaiah D
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1047-54. PubMed ID: 7980576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of vitamin C in oxidative modification of low-density lipoprotein induced by macrophage and copperion].
    Chen Y; Yang Q; Yang Y; Zhang X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):25-9. PubMed ID: 11955344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease.
    Draczynska-Lusiak B; Doung A; Sun AY
    Mol Chem Neuropathol; 1998 Feb; 33(2):139-48. PubMed ID: 9565971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oxidative modification of low-density lipoproteins by macrophages.
    Leake DS; Rankin SM
    Biochem J; 1990 Sep; 270(3):741-8. PubMed ID: 2122885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
    Jialal I; Grundy SM
    J Clin Invest; 1991 Feb; 87(2):597-601. PubMed ID: 1991843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Tocopherol, ascorbic acid, and rutin inhibit synergistically the copper-promoted LDL oxidation and the cytotoxicity of oxidized LDL to cultured endothelial cells.
    Nègre-Salvayre A; Mabile L; Delchambre J; Salvayre R
    Biol Trace Elem Res; 1995; 47(1-3):81-91. PubMed ID: 7779579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants.
    Guyton JR; Lenz ML; Mathews B; Hughes H; Karsan D; Selinger E; Smith CV
    Atherosclerosis; 1995 Dec; 118(2):237-49. PubMed ID: 8770318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbic acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein formation.
    Hwang J; Peterson H; Hodis HN; Choi B; Sevanian A
    Atherosclerosis; 2000 Jun; 150(2):275-84. PubMed ID: 10856519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both HDL3 and HDL2 exert a powerful anti-oxidative and protective effect against acceleration of oxidative modification of LDL by ascorbic acid.
    Sakuma N; Saeki T; Yajima K; Hibino T; Yoshida T; Mizuno H; Mukai S; Sakata S; Kunimatsu M; Kimura G
    J Nutr Sci Vitaminol (Tokyo); 2005 Apr; 51(2):75-9. PubMed ID: 16022192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition sites on rat liver cells for oxidatively modified beta-very low density lipoproteins.
    de Rijke YB; Hessels EM; van Berkel TJ
    Arterioscler Thromb; 1992 Jan; 12(1):41-9. PubMed ID: 1731857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity.
    Morel DW; Chisolm GM
    J Lipid Res; 1989 Dec; 30(12):1827-34. PubMed ID: 2621411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein.
    Jialal I; Vega GL; Grundy SM
    Atherosclerosis; 1990 Jun; 82(3):185-91. PubMed ID: 2375783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.
    Koo C; Wernette-Hammond ME; Garcia Z; Malloy MJ; Uauy R; East C; Bilheimer DW; Mahley RW; Innerarity TL
    J Clin Invest; 1988 May; 81(5):1332-40. PubMed ID: 3163347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-mediated reduction in the expression of endothelial nitric oxide synthase.
    Yoshida H; Sasaki K; Namiki Y; Sato N; Tada N
    Atherosclerosis; 2005 Mar; 179(1):97-102. PubMed ID: 15721014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antioxidants and fatty acids on low-density-lipoprotein oxidation.
    Fuller CJ; Jialal I
    Am J Clin Nutr; 1994 Dec; 60(6 Suppl):1010S-1013S. PubMed ID: 7977141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of low-density lipoprotein-induced inhibition of intercellular communication by antioxidants and high-density lipoproteins.
    Zwijsen RM; de Haan LH; Kuivenhoven JA; Nusselder IC
    Food Chem Toxicol; 1991 Sep; 29(9):615-20. PubMed ID: 1937292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of natural antioxidants on in vitro lipoprotein oxidation.
    Dobreanu M; Módy E
    Rom J Intern Med; 1997; 35(1-4):55-62. PubMed ID: 9562653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.